Works by Neven, Patrick

Results: 138
    1
    2

    Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor‐Positive, HER‐2 Negative Breast Cancer.

    Published in:
    Oncologist, 2019, v. 24, n. 2, p. 165, doi. 10.1634/theoncologist.2018-0176
    By:
    • Van Asten, Kathleen;
    • Slembrouck, Laurence;
    • Olbrecht, Siel;
    • Jongen, Lynn;
    • Brouckaert, Olivier;
    • Wildiers, Hans;
    • Floris, Giuseppe;
    • Van Limbergen, Erik;
    • Weltens, Caroline;
    • Smeets, Ann;
    • Paridaens, Robert;
    • Giobbie‐Hurder, Anita;
    • Regan, Meredith M.;
    • Viale, Giuseppe;
    • Thürlimann, Beat;
    • Vergote, Ignace;
    • Christodoulou, Evangelia;
    • Van Calster, Ben;
    • Neven, Patrick
    Publication type:
    Article
    3

    Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02058-x
    By:
    • Van Baelen, Karen;
    • Nguyen, Ha-Linh;
    • Richard, François;
    • Zels, Gitte;
    • Karsten, Maria Margarete;
    • Nader-Marta, Guilherme;
    • Vermeulen, Peter;
    • Dirix, Luc;
    • Dordevic, Adam David;
    • de Azambuja, Evandro;
    • Larsimont, Denis;
    • Maetens, Marion;
    • Biganzoli, Elia;
    • Wildiers, Hans;
    • Smeets, Ann;
    • Nevelsteen, Ines;
    • Neven, Patrick;
    • Floris, Giuseppe;
    • Desmedt, Christine
    Publication type:
    Article
    4
    5
    6

    Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.

    Published in:
    2020
    By:
    • Ribi, Karin;
    • Luo, Weixiu;
    • Colleoni, Marco;
    • Karlsson, Per;
    • Chirgwin, Jacquie;
    • Aebi, Stefan;
    • Jerusalem, Guy;
    • Neven, Patrick;
    • Di Lauro, Vincenzo;
    • Gomez, Henry L.;
    • Ruhstaller, Thomas;
    • Abdi, Ehtesham;
    • Biganzoli, Laura;
    • Müller, Bettina;
    • Barbeaux, Annelore;
    • Graas, Marie-Pascale;
    • Rabaglio, Manuela;
    • Francis, Prudence A.;
    • Foukakis, Theodoros;
    • Pagani, Olivia
    Publication type:
    corrected article
    7
    8

    Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.

    Published in:
    2019
    By:
    • Ribi, Karin;
    • Luo, Weixiu;
    • Colleoni, Marco;
    • Karlsson, Per;
    • Chirgwin, Jacquie;
    • Aebi, Stefan;
    • Jerusalem, Guy;
    • Neven, Patrick;
    • Di Lauro, Vincenzo;
    • Gomez, Henry L.;
    • Ruhstaller, Thomas;
    • Abdi, Ehtesham;
    • Biganzoli, Laura;
    • Müller, Bettina;
    • Barbeaux, Annelore;
    • Graas, Marie-Pascale;
    • Rabaglio, Manuela;
    • Francis, Prudence A.;
    • Foukakis, Theodoros;
    • Pagani, Olivia
    Publication type:
    journal article
    9
    10

    Nonlinear Mixed‐Effects Model of Z‐Endoxifen Concentrations in Tamoxifen‐Treated Patients from the CEPAM Cohort.

    Published in:
    Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 3, p. 690, doi. 10.1002/cpt.3238
    By:
    • Mc Laughlin, Anna M.;
    • Helland, Thomas;
    • Klima, Fenja;
    • Koolen, Stijn L.W.;
    • van Schaik, Ron H.N.;
    • Mathijssen, Ron H.J.;
    • Neven, Patrick;
    • Swen, Jesse J.;
    • Guchelaar, Henk‐Jan;
    • Dalenc, Florence;
    • White‐Koning, Melanie;
    • Michelet, Robin;
    • Mikus, Gerd;
    • Schroth, Werner;
    • Mürdter, Thomas;
    • Brauch, Hiltrud;
    • Schwab, Matthias;
    • Søiland, Håvard;
    • Mellgren, Gunnar;
    • Thomas, Fabienne
    Publication type:
    Article
    11

    Obesity Alters Endoxifen Plasma Levels in Young Breast Cancer Patients: A Pharmacometric Simulation Approach.

    Published in:
    Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 3, p. 661, doi. 10.1002/cpt.1960
    By:
    • Mueller‐Schoell, Anna;
    • Klopp‐Schulze, Lena;
    • Schroth, Werner;
    • Mürdter, Thomas;
    • Michelet, Robin;
    • Brauch, Hiltrud;
    • Huisinga, Wilhelm;
    • Joerger, Markus;
    • Neven, Patrick;
    • Koolen, Stijn L.W.;
    • Mathijssen, Ron H.J.;
    • Copson, Ellen;
    • Eccles, Diana;
    • Chen, Sylvia;
    • Chowbay, Balram;
    • Tfayli, Arafat;
    • Zgheib, Nathalie K.;
    • Schwab, Matthias;
    • Kloft, Charlotte
    Publication type:
    Article
    12
    13

    Bosutinib in Combination With the Aromatase Inhibitor Letrozole: A Phase II Trial in Postmenopausal Women Evaluating First-Line Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer.

    Published in:
    Oncologist, 2014, v. 19, n. 4, p. 348, doi. 10.1634/theoncologist.2014-0021
    By:
    • Moy, Beverly;
    • Neven, Patrick;
    • Lebrun, Fabienne;
    • Bellet, Meritxell;
    • Xu, Binghe;
    • Sarosiek, Tomasz;
    • Chow, Louis;
    • Goss, Paul;
    • Zacharchuk, Charles;
    • Leip, Eric;
    • Turnbull, Kathleen;
    • Bardy‐Bouxin, Nathalie;
    • Duvillié, Ladan;
    • Láng, István
    Publication type:
    Article
    14

    Bosutinib in Combination With the Aromatase Inhibitor Exemestane: A Phase II Trial in Postmenopausal Women With Previously Treated Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer.

    Published in:
    Oncologist, 2014, v. 19, n. 4, p. 346, doi. 10.1634/theoncologist.2014-0022
    By:
    • Moy, Beverly;
    • Neven, Patrick;
    • Lebrun, Fabienne;
    • Bellet, Meritxell;
    • Xu, Binghe;
    • Sarosiek, Tomasz;
    • Chow, Louis;
    • Goss, Paul;
    • Zacharchuk, Charles;
    • Leip, Eric;
    • Turnbull, Kathleen;
    • Bardy‐Bouxin, Nathalie;
    • Duvillié, Ladan;
    • Láng, István
    Publication type:
    Article
    15
    16
    17
    18
    19

    Authors' reply.

    Published in:
    BJOG: An International Journal of Obstetrics & Gynaecology, 1994, v. 101, n. 7, p. 646, doi. 10.1111/j.1471-0528.1994.tb13666.x
    By:
    • Neven, Patrick;
    • Shepherd, John H.
    Publication type:
    Article
    20
    21
    22

    The added value of geriatric assessment in evaluating a patient's Health‐Related Quality‐of‐Life: A study in ≥70‐year‐old early‐stage invasive breast cancer patients.

    Published in:
    European Journal of Cancer Care, 2020, v. 29, n. 5, p. 1, doi. 10.1111/ecc.13278
    By:
    • Quinten, Chantal;
    • Kenis, Cindy;
    • Hamaker, Marije;
    • Coolbrandt, Annemarie;
    • Brouwers, Barbara;
    • Dal Lago, Lissandra;
    • Neven, Patrick;
    • Vuylsteke, Peter;
    • Debrock, Guy;
    • Van Den Bulck, Heidi;
    • Smeets, Ann;
    • Schöffski, Patrick;
    • Wedding, Ulrich;
    • Wildiers, Hans
    Publication type:
    Article
    23
    24
    25
    26

    Reporting on invasive lobular breast cancer in clinical trials: a systematic review.

    Published in:
    NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00627-5
    By:
    • Van Baelen, Karen;
    • Van Cauwenberge, Josephine;
    • Maetens, Marion;
    • Beck, Gabriela;
    • Camden, Ann;
    • Chase, Megan-Claire;
    • Fraser, Valerie;
    • Freeney, Siobhan;
    • Hutcheson, Laurie;
    • Levine, Julia K.;
    • Lien, Tone;
    • Terveer, Rian;
    • Turner, Claire;
    • Senkus, Elzbieta;
    • Jankowitz, Rachel C.;
    • Vandecaveye, Vincent;
    • Floris, Giuseppe;
    • Neven, Patrick;
    • Wildiers, Hans;
    • Sawyer, Elinor
    Publication type:
    Article
    27

    Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

    Published in:
    2022
    By:
    • Gombos, Andrea;
    • Venet, David;
    • Ameye, Lieveke;
    • Vuylsteke, Peter;
    • Neven, Patrick;
    • Richard, Vincent;
    • Duhoux, Francois P.;
    • Laes, Jean-Francois;
    • Rothe, Françoise;
    • Sotiriou, Christos;
    • Paesmans, Marianne;
    • Awada, Ahmad;
    • Guiot, Thomas;
    • Flamen, Patrick;
    • Piccart-Gebhart, Martine;
    • Ignatiadis, Michail;
    • Gebhart, Géraldine
    Publication type:
    Correction Notice
    28

    FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

    Published in:
    NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00331-8
    By:
    • Gombos, Andrea;
    • Venet, David;
    • Ameye, Lieveke;
    • Vuylsteke, Peter;
    • Neven, Patrick;
    • Richard, Vincent;
    • Duhoux, Francois P.;
    • Laes, Jean-Francois;
    • Rothe, Françoise;
    • Sotiriou, Christos;
    • Paesmans, Marianne;
    • Awada, Ahmad;
    • Guiot, Thomas;
    • Flamen, Patrick;
    • Piccart-Gebhart, Martine;
    • Ignatiadis, Michail;
    • Gebhart, Géraldine
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2015, v. 154, n. 3, p. 543, doi. 10.1007/s10549-015-3634-6
    By:
    • Leyland-Jones, Brian;
    • Gray, Kathryn;
    • Abramovitz, Mark;
    • Bouzyk, Mark;
    • Young, Brandon;
    • Long, Bradley;
    • Kammler, Roswitha;
    • Dell'Orto, Patrizia;
    • Biasi, Maria;
    • Thürlimann, Beat;
    • Harvey, Vernon;
    • Neven, Patrick;
    • Arnould, Laurent;
    • Maibach, Rudolf;
    • Price, Karen;
    • Coates, Alan;
    • Goldhirsch, Aron;
    • Gelber, Richard;
    • Pagani, Olivia;
    • Viale, Giuseppe
    Publication type:
    Article
    39
    40

    CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.

    Published in:
    Breast Cancer Research & Treatment, 2015, v. 151, n. 2, p. 373, doi. 10.1007/s10549-015-3378-3
    By:
    • Leyland-Jones, Brian;
    • Gray, Kathryn;
    • Abramovitz, Mark;
    • Bouzyk, Mark;
    • Young, Brandon;
    • Long, Bradley;
    • Kammler, Roswitha;
    • Dell'Orto, Patrizia;
    • Biasi, Maria;
    • Thürlimann, Beat;
    • Lyng, Maria;
    • Ditzel, Henrik;
    • Harvey, Vernon;
    • Neven, Patrick;
    • Treilleux, Isabelle;
    • Rasmussen, Birgitte;
    • Maibach, Rudolf;
    • Price, Karen;
    • Coates, Alan;
    • Goldhirsch, Aron
    Publication type:
    Article
    41

    Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials.

    Published in:
    Breast Cancer Research & Treatment, 2015, v. 150, n. 1, p. 127, doi. 10.1007/s10549-015-3287-5
    By:
    • Fontanella, Caterina;
    • Lederer, Bianca;
    • Gade, Stephan;
    • Vanoppen, Mieke;
    • Blohmer, Jens;
    • Costa, Serban;
    • Denkert, Carsten;
    • Eidtmann, Holger;
    • Gerber, Bernd;
    • Hanusch, Claus;
    • Hilfrich, Jörn;
    • Huober, Jens;
    • Schneeweiss, Andreas;
    • Paepke, Stefan;
    • Jackisch, Christian;
    • Mehta, Keyur;
    • Nekljudova, Valentina;
    • Untch, Michael;
    • Neven, Patrick;
    • Minckwitz, Gunter
    Publication type:
    Article
    42

    Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.

    Published in:
    Breast Cancer Research & Treatment, 2014, v. 145, n. 2, p. 371, doi. 10.1007/s10549-014-2930-x
    By:
    • Donders, Gilbert;
    • Neven, Patrick;
    • Moegele, Maximilian;
    • Lintermans, Anneleen;
    • Bellen, Gert;
    • Prasauskas, Valdas;
    • Grob, Philipp;
    • Ortmann, Olaf;
    • Buchholz, Stefan
    Publication type:
    Article
    43

    A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2012, v. 134, n. 3, p. 1149, doi. 10.1007/s10549-012-2126-1
    By:
    • Schuler, Martin;
    • Awada, Ahmad;
    • Harter, Philipp;
    • Canon, Jean;
    • Possinger, Kurt;
    • Schmidt, Marcus;
    • Grève, Jacques;
    • Neven, Patrick;
    • Dirix, Luc;
    • Jonat, Walter;
    • Beckmann, Matthias;
    • Schütte, Jochen;
    • Fasching, Peter;
    • Gottschalk, Nina;
    • Besse-Hammer, Tatiana;
    • Fleischer, Frank;
    • Wind, Sven;
    • Uttenreuther-Fischer, Martina;
    • Piccart, Martine;
    • Harbeck, Nadia
    Publication type:
    Article
    44
    45
    46
    47
    48
    49

    A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy.

    Published in:
    Breast Cancer Research & Treatment, 2008, v. 110, n. 2, p. 327, doi. 10.1007/s10549-007-9726-1
    By:
    • Stephen Johnston;
    • Vladimir Semiglazov;
    • George Manikhas;
    • Dominique Spaeth;
    • Gilles Romieu;
    • David Dodwell;
    • Andrew Wardley;
    • Patrick Neven;
    • Annick Bessems;
    • Youn Park;
    • Peter De Porre;
    • Juan Perez Ruixo;
    • Angela Howes
    Publication type:
    Article
    50